Delivery Order SPE2DR25D1002-SPE2DR26FGM9J
- Not listed
- The Defense Logistics Agency awarded a $6,103.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections (0.5 ml), a diabetes medication. The contract is non-competitive with no set-aside designation and is scheduled for completion by January 12, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this order, with its parent company being Cencora, Inc. (doing business as...
- The Defense Logistics Agency awarded a delivery order valued at $1,005.80 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. The award, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance for this order. As a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a $9,621.44 delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen (0.5 ml), a diabetes medication, with a completion date of November 5, 2025. This non-set-aside, competitively awarded contract reflects firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,267.45 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pen (0.5 mL), a diabetes medication. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of April 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,607.06 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pen (0.5 mL), a diabetes medication. This competitively awarded, firm fixed price contract was executed on July 24, 2025, with an ultimate completion date of July 25, 2025. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,574.73 to supply Mounjaro 7.5 mg/0.5 mL pen injectors, a diabetes medication. The order was competitively awarded without set-aside designation and is scheduled for completion by October 30, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,809.48 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. The award was made on November 20, 2025, with an ultimate completion date of November 21, 2025, under firm fixed price terms with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,580.52 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pens on November 13, 2025, with completion expected by November 14, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded procurement of this diabetes medication from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,635.27 for Mounjaro 5 mg/0.5 mL pen (0.5 mL), a diabetes medication, with an ultimate completion date of July 15, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $8,123.67 delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen (0.5 ml), a diabetes medication, with an ultimate completion date of November 28, 2025. This is a firm fixed-price delivery order under a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement supporting military and...
- SPE2DR25D1002Indefinite Delivery Contract
- SPE2DR25D1002-SPE2DR26FGM9JDelivery Order
The Defense Logistics Agency awarded a $5,623.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen (0.5 ml), a diabetes medication administered via auto-injector. The contract, with an ultimate completion date of January 16, 2026, was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The award is a child delivery order under the parent company Cencora, Inc. (doing business as AmerisourceBergen), which holds a significant $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical designated as SPE2DX and running through December 2026. This delivery order is executed under the broader pharmaceutical supply arrangement supporting military healthcare programs globally. The IDC vehicle enables DLA to procure a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. AmerisourceBergen's contract awards demonstrate consistent capability to fulfill federal medical supply requirements through open competition, with pricing structured as firm fixed-price arrangements across a range of transaction values. The company also serves other federal healthcare systems including the Defense Health Agency and U.S. Coast Guard through this flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 1/14/26 |